Shanghai Aucta Pharmaceuticals Co., Ltd. – FDA Inspection, May 1, 2024

Record Details

This FDA Inspection record concerns Shanghai Aucta Pharmaceuticals Co., Ltd., with an inspection on May 1, 2024, issued by the Office of Inspections and Investigations, covering human drugs.

Company: Shanghai Aucta Pharmaceuticals Co., Ltd.
Inspection Date: May 1, 2024
Product Type: Human Drugs
Office: Office of Inspections and Investigations
Person: Jessica S. Estriplet (FDA Associated Person)

View Company Profile

ID · 068a14e9-d154-41db-b358-d31269bd48af

Inspection Facts

Inspection number: 1240857
FDA center: Human Drugs
Outcome: Form 483 issued

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Shanghai Aucta Pharmaceuticals Co., Ltd.

FDA Inspection

Shanghai Aucta Pharmaceuticals Co., Ltd.May 1, 2024

Shanghai Aucta Pharmaceuticals Co., Ltd. – FDA Inspection, May 1, 2024

Record Details

This FDA Inspection record concerns Shanghai Aucta Pharmaceuticals Co., Ltd., with an inspection on May 1, 2024, issued by the Office of Inspections and Investigations, covering human drugs.